NEW YORK, July 20, 2017 /PRNewswire/ -- "Preimplantation genetic testing market projected to grow at a CAGR of 10.0%"

The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4 million in 2017, at a CAGR of 10.0%. Growing rate of infertility across the globe, increasing public-private investments in the field of preimplantation genetic testing, rising number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and high risk of chromosomal abnormalities in the fetus with increasing maternal age are some of the key factors driving the growth of this market. However, the high procedural cost associated with preimplantation genetic testing and unsupportive government regulations are the factors restraining the growth of this market

On the basis of end users, the preimplantation genetic testing market is segmented into maternity centers & fertility clinics; hospitals, diagnostic labs, and service providers; and research laboratories & academic institutes. The maternity centers & fertility clinics segment accounted for the largest share of the global preimplantation genetic testing market in 2016 owing to the high success rate of treatments at fertility centers.

"APAC is projected to witness the highest growth during the forecast period "

While North America accounted for the largest share of the market in 2016, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022. This is owing to the focus of key market players in this region, growing number of ART & IVF procedures in the region, continuous decline in average fertility rate, government initiatives for expansion and modernization of healthcare infrastructure across respective countries, and growing medical tourism across APAC countries.

Breakdown of supply-side primary interviews: by company type, designation, and region:

This report studies the preimplantation genetic testing market based on technology, product & service, procedure type, application, and end user. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

This research focuses on various levels of analysis—industry trends, vendor dive analysis of 25 market players, and company profiles of top 15 market players—which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the preimplantation genetic testing market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on business strategies adopted by the major players in the preimplantation genetic testing market. The report analyzes the preimplantation genetic testing market based on technology, product & service, procedure type, application, end user, and region

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the preimplantation genetic testing market